|Articles|November 18, 2015

E-Book: Patient-Centric Approach to Product Commercialization

The industry’s much talked-about patient-centered approach requires more than lip-service and organizational redesigns. For the patient to emerge center stage in a commercial approach after having languished in the wings for years necessitates a totemic shift on the part of manufacturers that aligns both R&D and marketing in focusing squarely on patient needs to drive positive outcomes- clinical as well as behavioral. The result is a successful product with far greater commercial value in a crowded and highly competitive market. This eBook offers actionable strategies, targeted solutions, and specific directions on how to get there.


Related to this article

Pharmaceutical Executive Daily
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.